586 results on '"Phan, S"'
Search Results
2. Spotlight on: “dynamic PET/CT imaging”
3. Reducing Time-Lapse Seismic Data Acquisition Cost with Deep Learning
4. Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser
5. OS05.5.A NOVEL STUDY OF COGNITIVE REHABILITATION IMPROVING WORK PERFORMANCE IN PRIMARY BRAIN TUMOR
6. Investigation of charge multiplication in single crystalline CVD diamond particle detectors
7. An Integrated Deep Learning Workflow for Geologically Sequestered CO2 Monitoring
8. Time-lapse seismic data deblending with deep learning
9. Deep Learning to Enforce Repeatability of Time-Lapse Seismic Measurements
10. A 3D diamond detector for particle tracking
11. Synergistic catalysis for the synthesis of semiconducting polymers
12. Final Report
13. A Uniform and Isotropic Cytoskeletal Tiling Fills Dendritic Spines
14. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies
15. The Myofibroblast as an Inflammatory Cell in Pulmonary Fibrosis
16. Advances in molecular probe-based labeling tools and their application to multiscale multimodal correlated microscopies
17. Isoflurane Anesthetic Attenuates Lung Inflammation and Fibrosis
18. 168P Sacituzumab govitecan (SG) efficacy in patients with metastatic triple-negative breast cancer (mTNBC) by HER2 immunohistochemistry (IHC) status: Findings from the phase III ASCENT study
19. 189P Pharmacokinetics (PK) of sacituzumab govitecan (SG) in patients (Pts) with metastatic triple-negative breast cancer (mTNBC) and other solid tumors
20. P320 6-Thioguanine nucleotide levels are associated with trough levels of infliximab and adalimumab in Inflammatory Bowel Disease patients on combination therapy: A retrospective multicentre study
21. Delineate CO2 Plume Bodies by Mapping Subsurface Property Changes from Time-Lapse Seismic Gathers with Deep Learning
22. 258P Analysis of patients (pts) without an initial triple-negative breast cancer (TNBC) diagnosis (Dx) in the phase III ASCENT study of sacituzumab govitecan (SG) in brain metastases-negative (BMNeg) metastatic TNBC (mTNBC)
23. PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
24. Arabidopsis ROOT UV-B SENSITIVE 1 and 2 Interact with Aminotransferases to Regulate Vitamin B6 Homeostasis
25. Chemotactic Factor for Tumor Cells Derived from the C5a Fragment of Complement Component C5
26. OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study
27. FP13.03 IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC
28. Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFβ
29. 375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC
30. 0544 Reconsidering Stimulus Control: Activities in Bed Associated with Sleep-Related Outcomes
31. Sparse force‑bearing bridges between neighboring synaptic vesicles
32. Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts
33. Glucocorticoid-induced down regulation of transforming growth factor-β1 in adult rat lung fibroblasts
34. Endothelial Cell Gene Expression of a Neutrophil Chemotactic Factor by TNF-$\alpha $, LPS, and IL-1$\beta $
35. A phase 1 trial of motexafin gadolinium and docetaxel for advanced solid tumors: 3171
36. Bilateral diffuse lamellar keratitis following bilateral simultaneous versus sequential laser in situ keratomileusis
37. Physics of Hard Sphere Experiment: Scattering, Rheology and Microscopy Study of Colloidal Particles
38. Density-Functional Theory for Nonuniform Polyatomic Fluids
39. P2.04-88 Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial
40. OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3
41. Final efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
42. IMpower133: Updated overall survival (OS) analysis of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)
43. Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis.
44. C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge.
45. Dynamics of Disorder-Order Transitions in Hard Sphere Colloidal Dispersions in micro-g
46. Dynamics of hard sphere colloidal dispersions
47. Primary efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
48. MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3)
49. OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer
50. Is the depressive effect of renewables on power prices contagious? A cross border econometric analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.